Lista de obras - Alessandro Gozzetti - Dominio Público Uruguay

13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia

artículo científico

A case of acute myelogenous leukemia: myelodysplastic syndrome with t(2;11)(p21;q23) without MLL rearrangement

artículo científico publicado en 2003

A case of adult acute myelocytic leukemia (M5a) with a near-tetraploid karyotype characterized by monosomies 5 and 16

artículo científico publicado en 2004

A case of i(11)(q10) as sole cytogenetic abnormality in a patient with acute lymphoblastic leukemia

scientific article published on 01 October 2004

A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report

artículo científico publicado en 2011

A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2.

artículo científico publicado en 2010

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

scientific article published on 18 February 2020

A novel t(6;7)(p24;q21) in a chronic myelocytic leukemia in complete cytogenetic remission after therapy with imatinib mesylate

artículo científico publicado en 2004

A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase.

artículo científico publicado en 2004

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

artículo científico publicado en 2011

Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia.

artículo científico publicado en 2006

Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis.

artículo científico publicado en 2012

An unusual presentation of chronic B-cell lymphocytic leukaemia.

artículo científico publicado en 2004

Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments

artículo científico publicado en 2015

Bortezomib and restoration of chemosensitivity

artículo científico publicado en 2009

Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study

artículo científico publicado en 2014

Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia

artículo científico publicado en 2016

CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate

artículo científico publicado en 2007

CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.

artículo científico publicado en 2002

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

artículo científico publicado en 2016

Central nervous system multiple myeloma

artículo científico publicado en 2016

Central nervous system multiple myeloma

artículo científico publicado en 2014

Central nervous system multiple myeloma: a different cytogenetic profile

artículo científico publicado en 2014

Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.

artículo científico publicado en 2016

Characterization of Ph-negative abnormal clones emerging during imatinib therapy

artículo científico publicado en 2007

Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia

artículo científico publicado en 2014

Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis

scientific article published on 28 June 2008

Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications

artículo científico publicado en 2010

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.

artículo científico publicado en 2009

Commentary

artículo científico publicado en 2013

Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination.

artículo científico publicado en 2010

Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia.

artículo científico publicado en 2005

Concomitant chronic myeloid leukemia and chronic lymphocytic leukemia: a different clonal origin shown by molecular cytogenetics

scientific article published on 01 January 2008

Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia

artículo científico publicado en 2007

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

artículo científico publicado en 2016

Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation.

artículo científico publicado en 2013

Cost of illness in patients with multiple myeloma in Italy: the CoMiM study

artículo científico publicado en 2013

Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.

artículo científico publicado en 2016

Cutaneous myeloma and bortezomib.

artículo científico publicado en 2009

Cytokeratin-positive interstitial cell neoplasm: a case report and classification issues.

artículo científico publicado en 2003

Daratumumab efficacy in extramedullary orbital myeloma

artículo científico publicado en 2020

Deletion 9q in a patient with concomitant myelodysplasia and non-Hodgkin lymphoma

artículo científico publicado en 2007

Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization

artículo científico publicado en 2001

Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients

scientific article published on 19 April 2020

EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma.

artículo científico publicado en 2012

Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2017

Effect of 5637 conditioned medium (CM) on the mitotic index in the cytogenetic evaluation of myeloproliferative disorders

artículo científico publicado en 2004

Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas.

artículo científico publicado en 2014

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.

artículo científico publicado en 2013

Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia

artículo científico publicado en 2012

Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI).

artículo científico publicado en 2003

Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy

artículo científico publicado en 2012

Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients.

artículo científico publicado en 2011

Extramedullary multifocal plasmacytoma relapse in multiple myeloma

scientific article published on 10 October 2011

Extramedullary myeloma relapses

artículo científico publicado en 2012

FLT3 Inhibitors in the Management of Acute Myeloid Leukemia

artículo científico publicado en 2016

Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma

artículo científico publicado en 2017

Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia

scientific article published on 03 February 2019

Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients.

artículo científico publicado en 2016

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

artículo científico publicado en 2021

Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients

scientific article published on 13 August 2019

Human Cytotoxic T Lymphocytes Form Dysfunctional Immune Synapses with B Cells Characterized by Non-Polarized Lytic Granule Release

artículo científico publicado en 2016

Human Cytotoxic T Lymphocytes Form Dysfunctional Immune Synapses with B Cells Characterized by Non-Polarized Lytic Granule Release.

artículo científico publicado en 2016

Hyperlipidemia in a myeloma patient after bortezomib treatment

artículo científico publicado en 2010

Hyperlipidemic myeloma

scientific article published on 02 February 2010

IgM myeloma: A multicenter retrospective study of 134 patients

artículo científico publicado en 2017

Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemia

artículo científico publicado en 2006

Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up

artículo científico publicado en 2012

Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation?

artículo científico publicado en 2006

Insights into JAK2-V617F mutation in CML

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

artículo científico publicado en 2020

Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay.

artículo científico publicado en 2008

Intravenous (IV) bortezomib infusion after non-response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?

artículo científico publicado en 2016

Isolated deletion of 6q in a patient with myelodysplastic syndrome

scientific article published on 01 July 2009

Lenalidomide efficacy in bortezomib-resistant myeloma ⬇️

artículo científico publicado el 1 de septiembre de 2010

Lenalidomide maintenance in myeloma

artículo científico publicado en 2012

Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion.

artículo científico publicado en 2009

Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma

artículo científico publicado en 2007

Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders

artículo científico publicado en 2004

Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia

artículo científico publicado en 2008

Low-level TP53 mutational load antecedes clonal expansion in chronic lymphocytic leukaemia

artículo científico publicado en 2018

Maintenance Therapy in Multiple Myeloma: Novel Concepts in Clinical Practice from Recent Clinical Trials

artículo científico publicado en 2015

Massive intravascular hemolysis: a fatal complication ofClostridium perfringenssepticemia in a patient with acute lymphoblastic leukemia

artículo científico publicado en 2005

Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results

artículo científico publicado en 2009

Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice

artículo científico publicado en 2020

Molecular Cytogenetic Analysis of B-CLL Patients with Aggressive Disease

article

Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.

artículo científico publicado en 2004

Multiple myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib

scientific article published on 01 March 2007

Myelodysplasia presenting as thoracic spinal epidural extramedullary hematopoiesis: a rare treatable cause of spinal cord myelopathy.

artículo científico publicado en 2011

Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia.

artículo científico publicado en 2013

Novel agents in CNS myeloma treatment

artículo científico publicado en 2014

Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders

scientific article published on 19 November 2014

Outcome and toxicity in the modern era of new drugs for multiple myeloma: a reappraisal for comparison with future investigational trials.

artículo científico publicado en 2010

POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis

artículo científico publicado en 2022

Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia

scientific article published on 01 April 2007

Physicians and end-of-life issues

artículo científico publicado en 2010

Pilot Study of Gemtuzumab Ozogamicin (GO), Fludarabine, Cytarabine and Idarubicin Combined Regimen (GO-FLAI) as First-Line Induction Therapy plus GO Alone as Consolidation Therapy for Elderly Acute Myeloid Leukemia Patients

artículo científico publicado en 2007

Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?

artículo científico publicado en 2020

Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection

artículo científico publicado en 2014

Plasmacytoma of the skull

artículo científico publicado en 2011

Predicting the clinical course of Hodgkin lymphoma

artículo científico publicado en 2010

Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes With Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients With Chronic Lymphocytic Leukemia From Senegal

artículo científico publicado en 2017

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients

artículo científico publicado en 2011

Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.

artículo científico publicado en 2018

Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation

artículo científico publicado en 1995

Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment.

artículo científico publicado en 2007

Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study

article by Michele Cavo et al published 10 June 2007 in Journal of Clinical Oncology

Reply to 'Rituximab activity in CD20-positive multiple myeloma'

artículo científico publicado en 2007

Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission.

artículo científico publicado en 2018

Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma

artículo científico publicado en 2010

Second Generation Proteasome Inhibitors in Multiple Myeloma

artículo científico publicado en 2016

Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients

artículo científico publicado en 2018

Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study

artículo científico publicado en 2017

Single Agent Lenalidomide Activity in Multiple Myeloma Relapse Evidenced Uniquely by CT/PET.

artículo científico publicado en 2012

Sixth nerve and superior division of third nerve palsy due to intracranial extension of multiple myeloma. A diagnostic challenge and differential diagnosis

artículo científico publicado en 2017

Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin

artículo científico publicado en 2010

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19

artículo científico publicado en 2020

The effects of zoledronic acid on serum lipids in multiple myeloma patients.

artículo científico publicado en 2008

The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors

artículo científico publicado en 2009

The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype.

artículo científico publicado en 2007

The role of haematopoietic stem cell-supported myeloablative therapy for the management of multiple myeloma

artículo científico publicado en 1995

Therapeutic Use of Brentuximab Vedotin in CD30+ Hematologic Malignancies

artículo científico publicado en 2016

Therapeutic advancements in multiple myeloma

artículo científico publicado en 2014

Thrombotic Thrombocytopenic Purpura Secondary to an Occult Adenocarcinoma

artículo científico publicado en 2005

Translocation(X;2)(q26;q11.2) in a patient with acute myeloid leukemia M2 evolved from essential thrombocytemia

scientific article published on 01 February 2010

Treatment of smoldering multiple myeloma

artículo científico publicado en 2013

Trisomy 12 and t(14;22)(q32;q11) in a Patient with B-cell Chronic Lymphocytic Leukemia

scientific article published on 01 October 2004

Trisomy 13 in a patient with acute myeloid leukemia M0 and unusual durable remission

artículo científico publicado en 2006

Trisomy 13 in a patient with idiopathic myelofibrosis

artículo científico publicado en 2005

Trisomy 22 as sole cytogenetic abnormality in acute monoblastic leukemia (M5b)

artículo científico publicado en 2006

Trisomy 8 in chronic lymphocytic leukemia: a report of two cases

artículo científico publicado en 2007

Unusual localizations of plasmacytoma

artículo científico publicado en 2011

Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia

artículo científico publicado en 2020

Very late relapse in a patient with chronic myeloid leukemia in sustained complete cytogenetic response under imatinib.

artículo científico publicado en 2010

Weekly bortezomib, pegylated liposomal doxorubicin, and dexamethasone is a safe and effective therapy for elderly patients with relapsed/refractory multiple myeloma

artículo científico publicado en 2010

Lista de obras de Alessandro Gozzetti

13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia

A case of acute myelogenous leukemia: myelodysplastic syndrome with t(2;11)(p21;q23) without MLL rearrangement

A case of adult acute myelocytic leukemia (M5a) with a near-tetraploid karyotype characterized by monosomies 5 and 16

A case of i(11)(q10) as sole cytogenetic abnormality in a patient with acute lymphoblastic leukemia

A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report

A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2.

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

A novel t(6;7)(p24;q21) in a chronic myelocytic leukemia in complete cytogenetic remission after therapy with imatinib mesylate

A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase.

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia.

Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis.

An unusual presentation of chronic B-cell lymphocytic leukaemia.

Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments

Bortezomib and restoration of chemosensitivity

Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study

Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia

CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate

CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

Central nervous system multiple myeloma

Central nervous system multiple myeloma

Central nervous system multiple myeloma: a different cytogenetic profile

Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.

Characterization of Ph-negative abnormal clones emerging during imatinib therapy

Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia

Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis

Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.

Commentary

Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination.

Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia.

Concomitant chronic myeloid leukemia and chronic lymphocytic leukemia: a different clonal origin shown by molecular cytogenetics

Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation.

Cost of illness in patients with multiple myeloma in Italy: the CoMiM study

Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.

Cutaneous myeloma and bortezomib.

Cytokeratin-positive interstitial cell neoplasm: a case report and classification issues.

Daratumumab efficacy in extramedullary orbital myeloma

Deletion 9q in a patient with concomitant myelodysplasia and non-Hodgkin lymphoma

Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization

Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients

EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma.

Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia.

Effect of 5637 conditioned medium (CM) on the mitotic index in the cytogenetic evaluation of myeloproliferative disorders

Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas.

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.

Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia

Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI).

Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy

Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients.

Extramedullary multifocal plasmacytoma relapse in multiple myeloma

Extramedullary myeloma relapses

FLT3 Inhibitors in the Management of Acute Myeloid Leukemia

Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma

Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia

Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients.

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients

Human Cytotoxic T Lymphocytes Form Dysfunctional Immune Synapses with B Cells Characterized by Non-Polarized Lytic Granule Release

Human Cytotoxic T Lymphocytes Form Dysfunctional Immune Synapses with B Cells Characterized by Non-Polarized Lytic Granule Release.

Hyperlipidemia in a myeloma patient after bortezomib treatment

Hyperlipidemic myeloma

IgM myeloma: A multicenter retrospective study of 134 patients

Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemia

Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up

Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation?

Insights into JAK2-V617F mutation in CML

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay.

Intravenous (IV) bortezomib infusion after non-response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?

Isolated deletion of 6q in a patient with myelodysplastic syndrome

Lenalidomide efficacy in bortezomib-resistant myeloma ⬇️

Lenalidomide maintenance in myeloma

Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion.

Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma

Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders